Complement-Based Drug Development Summit leaderboard
  • Tuesday, August 25, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 262

Author

Pharma Journalist 9023 posts 0 comments

Speaker Interview with Macarena Hernandez- Jimenez released for Oligonucleotide Therapeutics &…

Aug 4, 2022
SAE Media Group reports: Macarena Hernandez-Jimenez from aptaTargets S.L. discusses the challenges and breakthroughs in the oligonucleotide therapeutics field The Oligonucleotide…
Read More...

SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong

Aug 3, 2022
Sinovac Biotech Ltd. announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong…
Read More...

RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT…

Aug 3, 2022
Radiopharm Theranostics, a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that it has entered a…
Read More...

Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab

Aug 3, 2022
Kiniksa Pharmaceuticals, Ltd. announced a global license agreement with Roche and Genentech, a member of the Roche Group (Genentech), for the rights to develop and commercialize…
Read More...

Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and…

Aug 3, 2022
Sosei Group Corporation announce they have entered a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules that…
Read More...

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib

Aug 3, 2022
Rigel Pharmaceuticals, Inc. and Forma Therapeutics, Inc. announced that they have entered into an exclusive, worldwide license agreement to develop, manufacture and commercialize…
Read More...

New Sponsors announced for Pre-Filled Syringes San Francisco 2022 this September

Aug 3, 2022
SAE Media Group reports: Newly released brochure and new sponsors announced for the Pre-filled Syringes San Francisco, this September 19 - 20, 2022. SAE Media Group is proud to host…
Read More...

Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug…

Aug 2, 2022
Synthego announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional…
Read More...

Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants…

Aug 2, 2022
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that…
Read More...

TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for…

Aug 2, 2022
TransCode Therapeutics, Inc. the RNA oncology company, and The University of Texas MD Anderson Cancer Center (“MD Anderson”), announced a strategic alliance to advance TransCode’s…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.